Farther Finance Advisors, LLC Regencell Bioscience Holdings LTD Transaction History
Farther Finance Advisors, LLC
- $9.33 Trillion
- Q4 2025
A detailed history of Farther Finance Advisors, LLC transactions in Regencell Bioscience Holdings LTD stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 448 shares of RGC stock, worth $5,644. This represents 0.0% of its overall portfolio holdings.
Number of Shares
448
Previous 322
39.13%
Holding current value
$5,644
Previous $4.98 Million
89.11%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding RGC
# of Institutions
22Shares Held
625KCall Options Held
73.8KPut Options Held
105K-
Geode Capital Management, LLC Boston, MA420KShares$5.29 Million0.0% of portfolio
-
Squarepoint Ops LLC New York, NY51.2KShares$645,7370.0% of portfolio
-
Discovery Capital Management, LLC South Norwalk, CT46.2KShares$581,6910.06% of portfolio
-
Xtx Topco LTD London, X038.7KShares$488,0610.03% of portfolio
-
Morgan Stanley New York, NY37.8KShares$476,8090.0% of portfolio
About Regencell Bioscience Holdings Ltd
- Ticker RGC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 13,012,900
- Market Cap $164M
- Description
- Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated...